AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

HIV Vaccine Awareness Day Bulletin

HVAD Logo

The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections — the annual HIV infection rate globally fell by 22 percent from 2001 to 2011 — but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV…

May 18th HIV Vaccine Awareness Day (HVAD): A Conversation with Dr. Carl Dieffenbach

HVAD Logo

May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the…

New NIH Award Aims to Reduce Asian American Hepatitis B Disparities through Health Information Technology

Ronald Valdiserri

A new grant award by the National Institute on Minority Health and Health Disparities (NIMHD) will support the development of new Health Information Technology (HIT) strategies that increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander (AAPI) populations.  Hepatitis B virus (HBV) infection is…

Prevention and Treatment of HIV Infection in Infants Born to Infected Mothers: Need for a Fresh Look

dieffenbachfauci2

On Monday, March 4, 2013, at the Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Dr. Deborah Persaud of the Johns Hopkins University presented an intriguing case study of a child who by all measures seems to be cured of HIV infection. This single case has sparked significant conversation, debate, and optimism. This blog…

Daily-use HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study

blog.aids.gov

According to findings of a major HIV prevention trial presented Monday, March 4, 2013 at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), study participants who received daily oral pre-exposure prophylaxis (PrEP) did not experience any protection against HIV compared to those in the placebo arm, likely because very few were taking the study…

Toddler ‘Functionally Cured’ of HIV Infection, NIH-Supported Investigators Report

Dr. Persaud NIH

Discovery Provides Clues for Potentially Eliminating HIV Infection in Other Children Editor’s note: NIH issued this news release this afternoon about findings announced at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) which began today in Atlanta, Georgia. The session at which the investigators will be reporting their findings in detail will be webcast…

An AIDS-Free Generation

Dr. Nora Volkow

Despite great strides in treating HIV, and despite effective prevention strategies that have reduced its spread among many populations, about 50,000 new cases of HIV are still diagnosed each year. December 1, World AIDS Day, is a good time to remember not only how far we have come since HIV first appeared three decades ago,…

U.S. Conference on AIDS – Highlights from Day 2

Dr. Jack Whitescarver

The annual U.S. Conference on AIDS (USCA) continued Monday. Among the highlights was a plenary session that put the spotlight on research for an HIV cure. Advances in HIV Cure Research   The presentation, “Toward a Cure for HIV: The Need for Science, Collaboration, and Advocacy”, was moderated by Dr. Jack Whitescarver, Director of the Office…